Women’s Health Breakthroughs: WHI Restored, Endometriosis Test, Ιmpact of Microplastics, Hormone Therapy & More
Here’s a snapshot of the latest key developments in women’s health:
💥 HHS restores funding for the critical Women’s Health Initiative study, supporting vital aging and women’s health research.
🩺 A new study finds no definitive causal link between female infertility and most gynecological cancers, with only a small association noted with breast cancer.
🔬 Pearsanta begins a clinical study for its innovative blood-based endometriosis diagnostic test, MET, offering a potential non-invasive alternative to surgery.
💻 Health-E Commerce teams up with Wisp to expand virtual women’s health services, allowing customers to use tax-free funds for telehealth care.
🤰 Advantia Health and Mirvie partner to pilot a blood test predicting preeclampsia risk early in pregnancy for better preventive care.
📱 Trellis Health launches with 1.8 million dollars in funding to empower women through AI-driven personalized health insights.
👶 New research shows buprenorphine treatment significantly improves outcomes for pregnant women with opioid use disorder, lowering rates of maternal mortality, preterm births, C-sections, and neonatal withdrawal syndrome.
🔬 Microplastics are detected for the first time in human ovarian follicular fluid, raising concerns about impacts on reproductive health.
❤️ Analysis suggests hormone therapy may improve cardiovascular health biomarkers, including positive effects on cholesterol and lipoprotein(a), in menopausal women.
Stay updated on these exciting advancements shaping the future of Women’s Health!
📢 Stay Ahead in Women’s Health Research!
✅ Like, share, and subscribe for weekly updates on Women’s Health breakthroughs.
#WomensHealth #Endometriosis #MaternalHealth #Preeclampsia #HormoneTherapy #Microplastics #HealthcareInnovation #MedicalResearch #LucidQuest #ClinicalResearch #WomenInMedicine